|
1
|
Dai C, Bao L, Tan Y, Jiang C. The hidden breast lesions: A case report of bilateral breast cancer. JOURNAL OF CLINICAL ULTRASOUND : JCU 2022; 50:422-427. [PMID: 34953150 PMCID: PMC9302622 DOI: 10.1002/jcu.23117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/07/2021] [Revised: 11/09/2021] [Accepted: 12/13/2021] [Indexed: 06/14/2023]
Abstract
Bilateral breast cancer (BBC) is rare and is associated with an unfavorable prognosis. Consequently it is crucial to improve diagnostic performance of breast cancer in the clinical setting. We report a case of BBC in a 66-year-old woman and describe the imaging findings, including mammography, hand-held ultrasound, automated breast ultrasound, anatomical intelligence for breast ultrasound (AI-breast), and magnetic resonance imaging. Only AI-breast ultrasound successfully located the two tumors, while other imaging examinations failed to detect the tumor in the right breast.
Collapse
Affiliation(s)
- Chaochao Dai
- Department of UltrasonographyAffiliated Hangzhou First People's Hosptital, Zhejiang University School of MedicineHangzhouChina
| | - Lingyun Bao
- Department of UltrasonographyAffiliated Hangzhou First People's Hosptital, Zhejiang University School of MedicineHangzhouChina
| | - Yanjuan Tan
- Department of UltrasonographyAffiliated Hangzhou First People's Hosptital, Zhejiang University School of MedicineHangzhouChina
| | - Chenxiang Jiang
- Department of UltrasonographyAffiliated Hangzhou First People's Hosptital, Zhejiang University School of MedicineHangzhouChina
| |
Collapse
|
|
2
|
Saleh T, El-Sadoni M, Alhesa A, Awad H, Jaradat M, Al-Hazaimeh M, Dawoud R, Mryyian A, Azab B. Expression of Senescence and Apoptosis Biomarkers in Synchronous Bilateral Breast Cancer: A Case Report. ACTA ACUST UNITED AC 2021; 28:3836-3845. [PMID: 34677245 PMCID: PMC8535022 DOI: 10.3390/curroncol28050327] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2021] [Accepted: 09/28/2021] [Indexed: 01/10/2023]
Abstract
Background: Synchronous bilateral breast cancer (SBBC) provides a special condition where two independent breast tumors are exposed to cancer pharmacotherapy within a uniform pharmacokinetic milieu. Both senescence and apoptosis are established responses to therapy; however, they have potentially variable contributions to the overall outcome of treatment, which are yet to be determined. Methods: In this report, we describe the clinicopathological picture of two SBBC cases that received standard anticancer treatment and assess their expression profile of several molecular hallmarks of senescence and apoptosis. Results: Our analysis identified that synchronous tumors have variable expression profiles of both senescence- and apoptosis-associated biomarkers, despite comparable pathological responses to neoadjuvant chemotherapy and current survival rates. Conclusions: Our results highlight the variable expression of senescence- and apoptosis-associated markers in breast tumors (despite the shared somatic genetic background) and invites a large-scale assessment of both senescence and apoptosis in breast cancer tissue in vivo and their contribution to the pathological response and overall survival.
Collapse
Affiliation(s)
- Tareq Saleh
- Department of Basic Medical Sciences, Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan; (R.D.); (A.M.)
- Correspondence: ; Tel.: +962-53903333 (ext. 5574)
| | - Mohammed El-Sadoni
- Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan; (M.E.-S.); (A.A.); (H.A.); (B.A.)
| | - Ahmad Alhesa
- Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan; (M.E.-S.); (A.A.); (H.A.); (B.A.)
| | - Heyam Awad
- Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan; (M.E.-S.); (A.A.); (H.A.); (B.A.)
| | - Mahmoud Jaradat
- Department of General Surgery, Jordanian Royal Medical Services, Amman 11942, Jordan; (M.J.); (M.A.-H.)
| | - Mohammad Al-Hazaimeh
- Department of General Surgery, Jordanian Royal Medical Services, Amman 11942, Jordan; (M.J.); (M.A.-H.)
| | - Rand Dawoud
- Department of Basic Medical Sciences, Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan; (R.D.); (A.M.)
| | - Amel Mryyian
- Department of Basic Medical Sciences, Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan; (R.D.); (A.M.)
| | - Bilal Azab
- Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan; (M.E.-S.); (A.A.); (H.A.); (B.A.)
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA
| |
Collapse
|